Labcorp Holdings Inc
LH251.810USD
-2.860-1.12%
收盤 01/09, 16:00（美東）報價延遲15分鐘
20.90B總市值
24.56本益比TTM
關於 Labcorp Holdings Inc 公司
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Labcorp Holdings Inc簡介
公司代碼LH
公司名稱Labcorp Holdings Inc
上市日期Apr 24, 1991
CEOSchechter (Adam H)
員工數量70000
證券類型Ordinary Share
年結日Apr 24
公司地址358 S Main St
城市BURLINGTON
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編27215
電話13362291127
網址https://www.labcorp.com/
公司代碼LH
上市日期Apr 24, 1991
CEOSchechter (Adam H)
Labcorp Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.57K
-5745.00%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-2000.00%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+1972.00%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
8.67K
-4000.00%
Ms. Amy B. Summy
Ms. Amy B. Summy
Executive Vice President, Chief Marketing Officer
Executive Vice President, Chief Marketing Officer
5.30K
+757.00%
Mr. Mark S. Schroeder
Mr. Mark S. Schroeder
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer
4.96K
--
Mr. Akinbolade Oyegunwa
Mr. Akinbolade Oyegunwa
Executive Vice President and Chief Information and Technology Officer
Executive Vice President and Chief Information and Technology Officer
3.73K
+263.00%
Ms. Megan D. Bailey
Ms. Megan D. Bailey
Executive Vice President and President - Central Laboratories and International
Executive Vice President and President - Central Laboratories and International
3.59K
+191.00%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam H. Schechter
Mr. Adam H. Schechter
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
87.57K
-5745.00%
Dr. Brian J. Caveney, M.D., J.D.
Dr. Brian J. Caveney, M.D., J.D.
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
Executive Vice President, President, Early Development Research Laboratories, Chief Medical and Scientific Officer
30.07K
-2000.00%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Executive Vice President - Special Advisor, Strategy
Executive Vice President - Special Advisor, Strategy
22.53K
+1972.00%
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Independent Director
Independent Director
12.89K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Lead Independent Director
Lead Independent Director
12.84K
--
Ms. Kerrii B. Anderson, CPA
Ms. Kerrii B. Anderson, CPA
Independent Director
Independent Director
8.67K
-4000.00%
收入明細
單位: USD更新時間: 3月12日 週三
單位: USD更新時間: 3月12日 週三
FY2021
FY2020
FY2019
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
Northern America
13.09B
81.22%
Europe
2.05B
12.72%
Other Countries
976.40M
6.06%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 11月16日 週日
更新時間: 11月16日 週日
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.79%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Investment Management (US)
4.62%
Victory Capital Management Inc.
3.18%
Geode Capital Management, L.L.C.
2.56%
其他
72.54%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.79%
BlackRock Institutional Trust Company, N.A.
5.30%
State Street Investment Management (US)
4.62%
Victory Capital Management Inc.
3.18%
Geode Capital Management, L.L.C.
2.56%
其他
72.54%
股東類型
持股股東
佔比
Investment Advisor
50.39%
Investment Advisor/Hedge Fund
38.82%
Research Firm
2.40%
Pension Fund
1.76%
Hedge Fund
1.61%
Bank and Trust
1.56%
Sovereign Wealth Fund
1.25%
Individual Investor
0.36%
Family Office
0.26%
其他
1.59%
機構持股
更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
1803
80.86M
97.54%
-4.56M
2025Q3
1802
83.09M
100.23%
+765.81K
2025Q2
1825
81.46M
98.03%
-5.42M
2025Q1
1872
81.69M
97.58%
-5.17M
2024Q4
1872
81.10M
96.90%
-5.32M
2024Q3
1856
80.09M
95.55%
-6.82M
2024Q2
1876
81.29M
96.43%
-7.49M
2024Q1
1904
82.39M
97.73%
-8.65M
2023Q4
1947
83.11M
99.02%
-9.76M
2023Q3
1930
84.34M
99.29%
-7.18M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
9.78M
11.79%
-66.55K
-0.68%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.39M
5.3%
-10.58K
-0.24%
Sep 30, 2025
State Street Investment Management (US)
3.83M
4.62%
-31.13K
-0.81%
Sep 30, 2025
Victory Capital Management Inc.
2.64M
3.18%
+440.22K
+20.04%
Sep 30, 2025
Geode Capital Management, L.L.C.
2.12M
2.56%
+9.78K
+0.46%
Sep 30, 2025
Wellington Management Company, LLP
2.11M
2.54%
+289.03K
+15.91%
Sep 30, 2025
Allspring Global Investments, LLC
2.00M
2.41%
-4.51K
-0.23%
Sep 30, 2025
Select Equity Group, L.P.
1.84M
2.22%
-295.76K
-13.87%
Sep 30, 2025
Diamond Hill Capital Management Inc.
1.64M
1.98%
-181.26K
-9.94%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.25M
1.5%
-41.66K
-3.23%
Sep 30, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares U.S. Healthcare Providers ETF
3.32%
Knowledge Leaders Developed World ETF
2.73%
Thrivent Small-Mid Cap ESG ETF
2.26%
State Street SPDR S&P Health Care Services ETF
1.9%
Schwab Ariel Opportunities ETF
1.62%
Brandes US Value ETF
1.56%
Invesco S&P 500 Equal Weight Health Care ETF
1.52%
Madison Covered Call ETF
1.49%
Nuveen ESG Mid-Cap Value ETF
1.4%
Franklin Genomic Advancements ETF
1.25%
查看更多
iShares U.S. Healthcare Providers ETF
佔比3.32%
Knowledge Leaders Developed World ETF
佔比2.73%
Thrivent Small-Mid Cap ESG ETF
佔比2.26%
State Street SPDR S&P Health Care Services ETF
佔比1.9%
Schwab Ariel Opportunities ETF
佔比1.62%
Brandes US Value ETF
佔比1.56%
Invesco S&P 500 Equal Weight Health Care ETF
佔比1.52%
Madison Covered Call ETF
佔比1.49%
Nuveen ESG Mid-Cap Value ETF
佔比1.4%
Franklin Genomic Advancements ETF
佔比1.25%
分紅派息
近5年累計派現
692.30M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Oct 08, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 11, 2025 going ex on Nov 26, 2025
Nov 26, 2025
Dec 11, 2025
Nov 26, 2025
Jul 10, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 11, 2025 going ex on Aug 28, 2025
Aug 28, 2025
Sep 11, 2025
Aug 28, 2025
Apr 10, 2025
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 11, 2025 going ex on May 29, 2025
May 29, 2025
Jun 11, 2025
May 29, 2025
Jan 09, 2025
LH.NB Final Cash Dividend of gross USD 0.72 paid on Mar 12, 2025 going ex on Feb 27, 2025
Feb 27, 2025
Mar 12, 2025
Feb 27, 2025
Oct 10, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 13, 2024 going ex on Nov 26, 2024
Nov 26, 2024
Dec 13, 2024
Nov 26, 2024
Jul 25, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 13, 2024 going ex on Aug 29, 2024
Aug 29, 2024
Sep 13, 2024
Aug 29, 2024
Apr 11, 2024
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Jun 12, 2024 going ex on May 24, 2024
May 28, 2024
Jun 12, 2024
May 24, 2024
Jan 12, 2024
LH.NB Final Cash Dividend of gross USD 0.72 paid on Mar 13, 2024 going ex on Feb 26, 2024
Feb 27, 2024
Mar 13, 2024
Feb 26, 2024
Oct 12, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Dec 12, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Dec 12, 2023
Nov 07, 2023
Jul 13, 2023
LH.NB Interim Cash Dividend of gross USD 0.72 paid on Sep 08, 2023 going ex on Aug 07, 2023
Aug 08, 2023
Sep 08, 2023
Aug 07, 2023
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
常見問題
Labcorp Holdings Inc的前五大股東是誰？
Labcorp Holdings Inc的前五大股東如下：
The Vanguard Group, Inc.持有股份：9.78M佔總股份比例：11.79%。
BlackRock Institutional Trust Company, N.A.持有股份：4.39M佔總股份比例：5.30%。
State Street Investment Management (US)持有股份：3.83M佔總股份比例：4.62%。
Victory Capital Management Inc.持有股份：2.64M佔總股份比例：3.18%。
Geode Capital Management, L.L.C.持有股份：2.12M佔總股份比例：2.56%。
The Vanguard Group, Inc.持有股份：9.78M佔總股份比例：11.79%。
BlackRock Institutional Trust Company, N.A.持有股份：4.39M佔總股份比例：5.30%。
State Street Investment Management (US)持有股份：3.83M佔總股份比例：4.62%。
Victory Capital Management Inc.持有股份：2.64M佔總股份比例：3.18%。
Geode Capital Management, L.L.C.持有股份：2.12M佔總股份比例：2.56%。
Labcorp Holdings Inc的前三大股東類型是什麼？
Labcorp Holdings Inc 的前三大股東類型分別是：
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
有多少機構持有Labcorp Holdings Inc(LH)的股份？
截至2025Q4，共有1803家機構持有Labcorp Holdings Inc的股份，合計持有的股份價值約為80.86M，占公司總股份的97.54% 。與2025Q3相比，機構持股有所增加，增幅為-2.70%。
哪個業務部門對Labcorp Holdings Inc的收入貢獻最大？
在FY2021，--業務部門對Labcorp Holdings Inc的收入貢獻最大，創收--，占總收入的--% 。
